Get started
Author

Keerun Khela

Observed names: K Khela, K. Khela, Khela, Keerun
ORCID: 0000-0003-3487-5609
Observed ORCID: 0000-0003-3487-5609
OpenAlex ID: A5042390338
Patient‐reported pain severity and health‐related quality of life in patients with multiple myeloma in real world clinical practice
2021 · Heinz Ludwig, Abigail Lucy Bailey, et al. · Cancer Reports · 20
PDF
Patient and Caregiver Socioeconomic Burden of First-Line Systemic Therapy for Advanced Gastroesophageal Adenocarcinoma
2022 · Hong Xiao, David Bertwistle, et al. · Future Oncology · 14
Physical, Emotional and Social Pain Communication by Patients Diagnosed and Living with Multiple Myeloma
2021 · Barry Quinn, Heinz Ludwig, et al. · Pain Management · 14
Physician- and Patient-Reported Symptom Concordance and Association with Quality of Life in Hepatocellular Carcinoma
2022 · Andrea Leith, Urpo Kiiskinen, et al. · Future Oncology · 5
Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment
2023 · Hong Xiao, David Bertwistle, et al. · BMC Cancer · 4
PDF
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States
2021 · Matthew J. Monberg, Jennifer P. Hall, et al. · European Journal of Gynaecological Oncology · 4
107P The evolving diagnostic and treatment landscape in metastatic non-small cell lung cancer (mNSCLC) across Europe: A real world evidence survey
2021 · H. Bailey, A. Lee, et al. · Annals of Oncology · 2
PDF
Pcn524 European Real-world Treatment Patterns of Systemic Therapies for Second Line (2l) Hepatocellular Carcinoma (hcc) Patients Who Previously Received Sorafenib
2019 · U. Kiiskinen, A. Rider, et al. · Value in Health · 2
PDF
Trends in physician perception and use of liquid biopsy in NSCLC within the US
2024 · Hope Bender, Keerun Khela · The Journal of Liquid Biopsy
PDF
96P Physician perceptions and the evolving landscape of next generation sequencing (NGS) use across EU4+UK
2024 · K. Khela · ESMO Open
POSB350 Real-World (RW) Patient-Reported Outcomes (PROs) in Frontline Maintenance Therapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UK
2022 · J Hanlon, H Bailey, et al. · Value in Health
1232P Understanding the diagnostic and treatment landscape in EGFRm advanced non-small cell lung cancer (aNSCLC) patients with exon 20 insertion mutations (Ex20ins)
2021 · H. Bailey, F. Nasirova, et al. · Annals of Oncology
PMU45 The Impact of COVID-19 on Patient Management across the EU and US
2021 · J. Piercy, E.A. Holdsworth, et al. · Value in Health
PDF
PCN340 Direct and Indirect Costs Associated with Unresectable Advanced or Metastatic (ADV/MET) Gastric Cancer (GC), Gastroesophageal Junction Cancer (GEJC) and Esophageal Adenocarcinoma (EAC) for Patients and Their Caregivers
2020 · J. Hall, K. Khela, et al. · Value in Health
PDF
PCN352 Treatment Patterns and Performance Status in Unresectable Advanced or Metastatic (ADV/MET) Gastric Cancer (GC), Gastroesophageal Junction Cancer (GEJC) and Esophageal Adenocarcinoma (EAC) Patients Receiving First LINE (1L) Treatment
2020 · J. Hall, K. Khela, et al. · Value in Health
1433P Impact on work productivity in unresectable locally advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma patients and their caregivers
2020 · H. Xiao, J.P. Hall, et al. · Annals of Oncology
PDF
1469P The humanistic burden reported by patients with unresectable locally advanced or metastatic (adv/met) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): An international real-world survey
2020 · J.P. Hall, K. Khela, et al. · Annals of Oncology
Works count: 18
Citation count: 65
H-index: 4
I10-index: 3
Year
Topic
Type